Skip to main content
. Author manuscript; available in PMC: 2015 Feb 16.
Published in final edited form as: ASAIO J. 2014 Jan-Feb;60(1):44–48. doi: 10.1097/MAT.0000000000000011

Table 2.

Preimplant Characteristics for LVAD Patients

Characteristic Replacement (n = 30) Matched (n = 30) p Value DT LVAD Recipients (n = 201)
Age (years) 58.0 (47, 67) 67.5 (53, 73) 0.07 65 (53, 71)
Sex (% male) 66.7 80.0 0.38 73.6
BMI 30.3 (25.8, 35.3) 28.8 (25.5, 33.2) 0.93 28.5 (25.0, 33.7)
Heart failure etiology (% NICM) 36.6 56.7 0.19 42.3
Diabetes (%) 43.3 43.3 0.99 49.8
Hypertension (%) 60.0 56.7 0.99 52.2
Peripheral vascular disease (%) 6.7 13.3 0.67 9.45
Pulmonary disease (%) 20.0 23.3 0.99 22.9
Albumin (g/dl) 3.25 (2.8, 3.8) 3.45 (2.9, 3.7) 0.95 3.20 (2.6, 3.6)
Creatinine (mg/dl) 1.4 (1.2, 1.7) 1.7 (1.2, 2.0) 0.34 1.5 (1.1, 1.9)
Hematocrit (%) 32.0 (28, 37) 33.0 (31, 37) 0.28 34.0 (30, 38)
Prothombin time (second) 14.8 (12.8, 16) 14.2 (12.9, 16) 0.99 14.20 (13.2, 15.9)
Central venous pressure 11 (4, 17) 12 (8, 18) 0.38 12.00 (8, 18)
Preoperative support (%)
  Inotropes 30.0 40.0 0.59 79.1
  IABP 6.6 13.3 0.67 33.4
  Mechanical ventilation 10.0 13.3 0.99 7.0
Previous sternotomy (%) 100 100 0.99 44.8
Emergent case (%) 30.0 20.0 0.55 12.4

Continuous variables are expressed as median (25th, 75th percentile).

BMI, body mass index; IABP, intra-aortic balloon pump; LVAD, left ventricular assist device; NICM, nonischemic cardiomyopathy.